NHS Advances in the Treatment of Alzheimer’s Disease

Professor Farooq Khan, Clinical Lead for Dementia in the Midlands, NHS England
Dementia Care Conference 2024

At the 2024 Dementia Care Conference, Professor Farooq Khan, Clinical Lead for Dementia in the Midlands with NHS England, presented a detailed case study highlighting recent advances in the treatment of Alzheimer’s disease. Professor Khan discussed the breakthrough developments in both diagnosis and treatment, with a focus on new molecules and biomarkers that could revolutionise Alzheimer’s care. Watch the full video above or read the summary below.

Progress in Alzheimer’s Research

For many years, progress in treating Alzheimer’s was slow despite extensive research efforts. Traditional treatments focused on managing symptoms rather than altering the disease’s progression. However, recent breakthroughs have brought new hope, particularly with the introduction of disease-modifying therapies.

One of the key advances Professor Khan discussed is the development of monoclonal antibodies such as Aducanumab, which targets the amyloid beta plaques responsible for neuron damage in Alzheimer’s patients. Although Aducanumab is currently approved in the United States, it is still under review by the NHS for use in the UK. This treatment, alongside others like Lecanemab, shows promising results in slowing cognitive and functional decline in patients with early-stage Alzheimer’s or mild cognitive impairment (MCI).

New Diagnostic Tools

The presentation emphasised the importance of early diagnosis in managing Alzheimer’s disease effectively. Advances in imaging techniques, such as amyloid PET scans, and the development of fluid biomarkers, like CSF and plasma markers, have improved diagnostic accuracy. These tools can detect Alzheimer’s pathology much earlier, even before clinical symptoms appear, potentially allowing for earlier intervention.

While these diagnostic tools are not yet widely available on the NHS, Professor Khan predicted that they would become more prevalent in the near future as new therapies gain approval.

Focus on Multi-Targeted Approaches

The importance of addressing multiple aspects of the disease, rather than focusing solely on amyloid plaques was outlined. Future therapies will likely involve multi-target approaches, tackling both amyloid and tau proteins, synaptic plasticity, neuroinflammation, and other factors contributing to cognitive decline. This multi-pronged strategy offers a more comprehensive approach to managing Alzheimer’s disease.

Implications for Dementia Care

Beyond pharmacological treatments, there is growing interest in non-pharmacological approaches, such as cognitive stimulation, exercise, and neurostimulation, to enhance the quality of life for people with dementia. Trials are also exploring ways to support caregivers, recognising the crucial role they play in managing Alzheimer’s disease in both home and formal care settings.

The Future of Alzheimer’s Research

Despite past challenges in Alzheimer’s research, Professor Khan remained optimistic about the future. With several promising treatments in development and a greater understanding of the disease’s pathology, Alzheimer’s care is on the brink of significant transformation. While current treatments aim to slow disease progression, future innovations may offer even more profound impacts on cognitive and functional abilities, improving the lives of patients and their families.

Professor Khan’s presentation at our Dementia Care Conference 2024 underscored the importance of continued research and collaboration within the medical community and the hope these advances offer to those affected by Alzheimer’s disease. For more insights on the NHS Workforce please see the event below:

View our latest UK Healthcare Workforce Event

Attend The UK Healthcare Workforce Event to learn from experts about retaining and improving the NHS workforce

• High-level keynotes will provide insights into the latest national updates from the NHS Long Term Workforce Plan and Developing Wrap-Around Staff Wellbeing Support Systems
• The event covers best practices case studies in recruitment, retention, mental health support, and inclusion and diversity.
• Network with senior colleagues, discuss shared challenges and learn practical strategies for workforce improvement through keynote speeches and interactive sessions.